Investment focus
With smart money and in line with United Nations’ sustainable development goals (SDG 3,4; 3,7; and 3,d), we want to contribute to the healthcare of tomorrow. As an investor, we have skin in the game and can be a trusted partner for guiding our portfolio through clinical and regulatory hurdles and help with the data collection.
We invest exclusively in regulated products and technologies, preferably from Series A onwards. HEMEX is a long-term investor and partner investing throughout the year 3-5 new projects and significant follow-up investments of existing portfolio companies. Our value is quality before quantity.
“Together, we can shape the future of healthcare. We are committed to positively impacting the healthcare sector by financing promising startups and supporting them along the way to ensure they achieve future milestones.”
What we expect from startups
- A dedicated and focused team.
- Innovative and game–changing solutions in the regulated healthcare sector.
- Founders with a focus on the development, open for smart money investors with potential involvement in clinical development.
- Credible solution with a realistic, sustainable business model and market fit.
- Clarity on patent and IP.
Investment process
- As smart money investor, we are a trusted long-term partner for initial and follow-up financing.
- We have an unbiased multi-step approach involving experts from the relevant fields.
- We ensure a resourceful, facts-based thorough, and objective selection to present to our investment committee for final decision.
1/8
Investment
request.
2/8
Pitch.
3/8
Screening.
4/8
Due Diligence.
5/8
Decision.
6/8
Transfer of funds.
7/8
Portfolio
management.
8/8
EXIT
IPO
Ready for investors?
Take 5 minutes to fill out The Funding Readiness Assessment developed by our partner Peak Spirit, and find out if your company is ready to talk to institutional investors.
Survey results, what next?
More than 80 points
Congratulations, your venture is ready to raise equity! To learn to successfully talk with investors sign up here
Less than 80 points
Your venture still shows some gaps, that should be addressed before raising equity. Get in touch for more info
Less than 60 points
Your venture still needs to address several topics before taking with investors. Get in touch for more info
Apply for investment
When your venture matches our expectations, apply by sending us an email* to ir@hemex.ch or by using the button below.
All cases will be carefully examined. We maintain a large network of experts from a variety of fields to ensure that all cases are assessed with appropriate expertise.
**Please be aware that we receive numerous applications, and we try to answer as quickly as possible. If you have not heard from us in three weeks, it means you have not been selected for further evaluation.
Get funding with our solutions
How can we help?
Do you have specific inquires about any of our services? Would you like to know more about us? Or just stop by? Feel free to reach to us, we'd love to hear from you!
Our offices
Hemex AG
Headquarters | Kasernenstrasse 30 | 4410 Liestal | Switzerland
Hemex Germany GmbH
c/o Loeba Treuhand GmbH, Wallbrunnstr. 24 | 79539 Loerrach | Germany
Hemex, LLC
The 5th Floor | 3801 Avalon Park East Blvd, Suite 200 | Orlando, FL 32828 | USA
Stop by our headquarters
- By car via A22 motorway take exit Altmarkt
- By train to Liestal SBB (7 min. on foot from train station)
- By plane from EuroAirport Basel-Mulhouse-Freiburg (EAP) by bus nr. 50 to Basel SBB then by train to Liestal SBB
Email us
Hemex AG
info@hemex.ch
firstname.lastname@hemex.ch
Hemex Germany GmbH
info@hemex-germany.de
firstname.lastname@hemex-germany.de
Hemex, LLC
info@hemex-us.com
firstname.lastname@hemex-us.com
Call us
Switzerland:
Mo-Fri 09:00-17:00 CET, our headquarters can be reached on (+41) 61-927-28-00
Germany:
Mo-Fri 09:00-17:00 CET, our EU office can be reached on (+49) 1512-568-48-92
USA:
Mo-Fri 7 a.m. to 6 p.m. EST, our headquarters can be reached on (+1) 689-219-8929
Emergencies:
24/7/365 emergency phone numbers:
(+41) 79-833-73-30 (Switzerland)
(+49) 1512-568-48-92 (Germany)